MF
AMRX icon

Magnetar Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Magnetar Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,001
Closed -$1.01M – 1157
2026
Q1 		$1.01M Buy
81,001
+70,799
+694% +$951K 0.01% 476
2025
Q4 		$129K Buy
+10,202
New +$117K ﹤0.01% 834
2025
Q2 		– Sell
-29,605
Closed -$248K – 886
2025
Q1 		$248K Sell
29,605
-18,199
-38% -$152K ﹤0.01% 614
2024
Q4 		$379K Buy
+47,804
New +$401K 0.01% 423
2021
Q3 		– Sell
-119,317
Closed -$611K – 1305
2021
Q2 		$611K Buy
+119,317
New +$678K 0.01% 838
2021
Q1 		– Sell
-551,792
Closed -$2.52M – 1037
2020
Q4 		$2.52M Buy
+551,792
New +$2.45M 0.04% 322
2018
Q3 		– Sell
-170,531
Closed -$2.8M – 509
2018
Q2 		$2.8M Buy
+170,531
New +$2.99M 0.04% 89

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Magnetar Financial's AMRX Position: Q2 2026 in Review

Magnetar Financial sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 81,001 shares — an estimated $1.01M sold.

Magnetar Financial first reported a position in AMRX in Q2 2018 and held it in 7 quarters. The position peaked at $2.8M in Q2 2018. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Magnetar Financial reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 81,001 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.01M.
  • Magnetar Financial first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • Magnetar Financial's Amneal Pharmaceuticals position peaked at $2.8M in Q2 2018.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.